A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis

被引：0
|
作者：
Rao, Shiavax J. [1 ]
Kumar, Kaushik [1 ]
Saleh, Nahar [1 ]
机构：
[1] MedStar Union Mem Hosp, Internal Med, Baltimore, MD 21218 USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 10期
关键词：
high anion gap metabolic acidosis; sglt-2; inhibitor; euglycemic dka; diabetic keto acidosis; sodium-glucose cotransporter-2 inhibitors;
D O I：
10.7759/cureus.30106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
While rare, serious adverse effects including euglycemic diabetic ketoacidosis (EDKA) have been associated with sodium-glucose cotransporter-2 inhibitor (SGLT2i) use. We present an interesting case of SGLT2i-induced EDKA occurring two years after initiation of therapy. Most patients with EDKA recover with prompt recognition and treatment. Patient education about identifying early signs remains a cornerstone of early identification and response to SGLT2i-induced EDKA.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] SGLT2 INHIBITOR-INDUCED EUGLYCEMIC DIABETIC KETOACIDOSIS
    Chawla, Ambreesh
    Healy, Austin
    Kim, Minha
    Sapru, Sunil
    [J]. CHEST, 2018, 154 (04) : 363A - 363A
  • [2] SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report
    Wang, Katherine M.
    Isom, Robert T.
    [J]. KIDNEY MEDICINE, 2020, 2 (02) : 218 - 221
  • [3] SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis
    Anis, K.
    Eldib, A.
    Mitri, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor
    Alhemeiri, Mohamed
    Alseddeeqi, Eiman
    [J]. CASE REPORTS IN ENDOCRINOLOGY, 2022, 2022
  • [5] Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report
    Klinkner, Gwen
    Steingraber-Pharr, Maggie
    [J]. AACN ADVANCED CRITICAL CARE, 2023, 34 (01) : 27 - 32
  • [6] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Yousaf, Zohaib
    Ata, Fateen
    Khan, Adeel Ahmad
    Razok, Almurtada
    Akram, Jaweria
    Ali, Elrazi Awadelkarim Hamid
    Abdalhadi, Ahmed
    Danjuma, Mohammed I.
    Al Mohanadi, Dabia Hamad S. H.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1431 - 1433
  • [7] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Zohaib Yousaf
    Fateen Ata
    Adeel Ahmad Khan
    Almurtada Razok
    Jaweria Akram
    Elrazi Awadelkarim Hamid Ali
    Ahmed Abdalhadi
    Mohammed I. Danjuma
    Dabia Hamad S. H. Al Mohanadi
    [J]. European Journal of Clinical Pharmacology, 2021, 77 : 1431 - 1433
  • [8] Euglycemic ketoacidosis induced by SGLT2 inhibitors
    Bacheley, M.
    Reznik, Y.
    [J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2022, 26 (01): : 33 - 34
  • [9] Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy
    Palmer, Biff F.
    Clegg, Deborah J.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (08): : 1284 - 1291
  • [10] A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
    Patel, Khyati
    Nair, Arun
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
12345